Company: TELO
Filing Date: 2025-11-20
Form Type: PREM14A
Source: 0001493152-25-024463
Chunk: 53

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: PREM14A
Chunk 53
---
 considered the reasons overall to be favorable to, and to support, its determination.

On October 15, 2025, TELO provided Moore with additional responses and supplementary material to support its forecasts.

The LOI was signed by both TELO and TELI on October 17, 2025.

At no point did TELO and TELI enter into a non-disclosure agreement that contained any don’t ask, don’t waive standstill provisions.

On November 10, 2025, Moore provided TELO’s and TELI’s management with a fairness opinion for the Exchange Ratio and valuation reports of TELO and TELI.

On November 10, 2025, the Board held a meeting to discuss the approval of the Merger Agreement and Exchange Ratio. Moore presented the Board with an analysis of its determination of TELO’s and TELI’s valuations. TELO’s and TELI’s management provided a discussion regarding the benefits of the Merger. TELO’s legal counsel provided a discussion on the potential conflicts of interest involved in the Merger, including those discussed in the section of this proxy statement titled “ The Merger—Interests of the TELO Directors, Executive Officers and Affiliate Shareholders in the Merger”, on page 34. The Board requested additional information from TELO regarding TELI’s capitalization table, the Warrants and TELO’s and TELI’s valuation reports. The Board also held an independent meeting without Erez Aminov to discuss the conflicts of interest related to Mr. Aminov involved with the Merger.

On November 17, 2025, the remaining four members of the Board held additional discussions relating to the Merger, including additional discussion regarding the potential conflicts of interest involved in the Merger, including those discussed in the section of this proxy statement titled “ The Merger—Interests of the TELO Directors, Executive Officers and Affiliate Shareholders in the Merger”, on page 34 of this proxy statement. The remaining three independent members of the Board met privately to discuss the Merger. The Board also reviewed the fairness opinion prepared by Moore in determining the Merger is fair to TELO shareholders. The Board thereafter unanimously approved the Merger, including all independent directors.

| 30 |

Moore Fairness Opinion and Valuation Reports

TELO retained Moore as financial advisor to TELO in connection with the Merger. TELI had previously never been subject to a third-party valuation. Moore was selected due to its